Condition
Chronic Lymphocytic Leukaemia clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Chronic Lymphocytic Leukaemia clinical trials that are recruiting, at sites in 25 countries (most in Spain (4), United States (4), Czechia (3)). By phase: Phase 2 (2), Phase 4 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 25Countries
Newest Chronic Lymphocytic Leukaemia clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| MK-1045-006: testing a new treatment for B-cell cancers like CLL and SLL | Phase 2 | Medellín, Antioquia and 7 other locations | Recruiting | Jul 16, 2026 |
| Acalabrutinib treatment for patients with chronic lymphocytic leukaemia and heart failure | Phase 4 | Charlotte, North Carolina and 22 other locations | Recruiting | Oct 22, 2024 |
| Evaluating AZD0486 for treating mature B-cell cancers | Phase 1/2 | Boston, Massachusetts and 65 other locations | Recruiting | Aug 21, 2024 |
| Testing tumor samples from patients with second cancers after gene therapy | — | Portland, Oregon and 7 other locations | Recruiting | Apr 10, 2024 |
| Evaluating the effects of nemtabrutinib in patients with blood cancers | Phase 2 | Springdale, Arkansas and 120 other locations | Recruiting | Jan 28, 2021 |
All recruiting trials (5)
-
MK-1045-006: testing a new treatment for B-cell cancers like CLL and SLL
This trial will test MK-1045 in people with relapsed or treatment‑refractory CLL/SLL to see if it’s safe and how well it works.
-
Acalabrutinib treatment for patients with chronic lymphocytic leukaemia and heart failure
This study is testing if a new drug called acalabrutinib is safe and effective for people with chronic lymphocytic leukaemia and heart failure compared to other treatment options.
-
Evaluating AZD0486 for treating mature B-cell cancers
This study is testing a new treatment called AZD0486 to see if it can help people with certain types of mature B-cell cancers feel better and improve their health.
-
Testing tumor samples from patients with second cancers after gene therapy
This study is testing tumor samples from patients who have had gene therapy to see if there's a link between the treatment and the development of a second cancer.
-
Evaluating the effects of nemtabrutinib in patients with blood cancers
This study is testing a new oral medication called nemtabrutinib to see if it can help people with blood cancers like chronic lymphocytic leukemia and Waldenström's macroglobulinemia feel better and stay safe.
Related topics
Quick answers
How many Chronic Lymphocytic Leukaemia clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 25 countries. The most sites are in Spain (4 trials), United States (4 trials), Czechia (3 trials), Germany (3 trials), Italy (3 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 4: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.